Low-Dose Methotrexate and Mucocutaneous Adverse Events: Results of a Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials.

Riyana LalaniHouchen LyuKathleen VanniDaniel H Solomon

Published in: Arthritis care & research (2020)

This meta-analysis gives more precise estimates of mucocutaneous adverse events that occur in rheumatic disease patients taking MTX. These estimates will help inform patient decision-making regarding MTX.

Keyphrases

systematic review
low dose
end stage renal disease
decision making
high dose
chronic kidney disease
ejection fraction
newly diagnosed
rheumatoid arthritis
prognostic factors
peritoneal dialysis
randomized controlled trial
meta analyses
patient reported outcomes